Drugs / SyB D-0701
last change Oct 2012 re-read 3 minutes ago

SyB D-0701

Developed for
radiation-induced disorder
Investigated by
SymBio Pharmaceuticals

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01700140 May 2011 → Oct 2012 radiation-induced disorder SymBio Pharmaceuticals Completed Missed primary

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SyB D-0701 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01700140 ↗